Inventor

CHEN MINHUA

US61 patents

⚠️ This page may combine multiple inventors who share the name “CHEN MINHUA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CHEN MINHUA

CRYSTAL PHARMATECH CO LTD

Crystal form of lenvatinib methanesulfonate salt and preparation method thereof

Crystalline form E of tafamidis meglumine, process for preparation and use thereof

Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of salt

Crystal form of JAK inhibitor and preparation method thereof

Co-crystal of a CDK inhibitor and an MEK inhibitor and process of preparation thereof

Crystaline forms of N-[6-(cis-2,6-dimethylmorpholine-4-yl)pyridine-3-yl]-2-Methyl-4′-(trifluoromethoxy) [1,1′-biphenyl]-3-Methanamide monophosphate, and process of preparation thereof

Crystalline form of AHU377, preparation method and use thereof

Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of salt

Crystalline form of lenvantinib mesylate and process of preparation thereof

Crystalline forms of AP26113, and preparation method thereof

Crystalline forms of selective S1P1 receptor modulator and preparation method thereof

Crystalline forms of lesinurad and its sodium salt

Crystal form of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxole-5-yl)cyclopropane formamido)-3-methylpyridine-2-yl)benzoic acid and preparation method thereof

Crystalline form A of obeticholic acid and preparation method thereof

Crystal form of neratinib maleate and preparation method therefor

Crystalline forms of trisodium supramolecular complex comprising valsartan and AHU-377 and methods thereof

CRYSTAL PHARMACEUTICAL SUZHOU CO LTD

Crystalline forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] amino} acetic acid and processes for preparation thereof

Crystal form of upadacitinib, preparation method therefor, and use thereof

Crystalline form of EB-1020, processes for preparation and use thereof

Crystal form of acalabrutinib and preparation method and use thereof

Galunisertib crystalline form, preparation method thereof and use thereof

Crystalline form of valbenazine ditosylate, processes for preparation thereof and use thereof

Crystalline forms of a fatty acid bile acid conjugate, preparation method thereof and use thereof

Crystalline form of orexin receptor antagonist, processes for preparation thereof and use thereof

Crystal form of lanifibranor, preparation method therefor, and use thereof

Crystal form of Baricitinib and preparation method thereof

Crystalline forms of ARN-509, preparation method and use thereof

Crystal form of Resmetirom, preparation method therefor, and use thereof

Crystal form of tafamidis and preparation method therefor and use thereof

Resmetirom crystal, preparation method for same, and uses thereof

Crystal forms of sodium-glucose co-transporter inhibitor, processes for preparation and use thereof

Crystalline forms of PLX3397 hydrochloride, processes for preparation and use thereof

RECEPTOS LLC

Crystalline form of ozanimod hydrochloride, and processes for preparation thereof

Crystal form of ozanimod hydrochloride and processes for preparation therefor

Crystalline forms of ozanimod and processes for preparation thereof

Crystalline forms of ozanimod and ozanimod hydrochloride, and processes for preparation thereof

Crystalline forms of ozanimod and ozanimod hydrochloride, and processes for preparation thereof

Crystalline forms of ozanimod and processes for preparation thereof

CHEN MINHUA

Magnifying glass with light

Magnifying glass with light

Fan blade

Fan

Crystalline forms of trisodium supramolecular complex comprising valsartan and AHU-377 and methods thereof

GLAXOSMITHKLINE IP NO 2 LTD

Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereof

Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereof

ANACOR PHARMACEUTICALS INC

Crystal forms of crisaborole in free form and preparation method and use thereof

Crystal forms of crisaborole in free form and preparation method and use thereof

CRYSTAL PHARMATECH INC

Crystalline form I of ibrutinib

CRYSTAL PHARMACEUTICAL (SUZHOU) CO LTD

Crystalline forms of a bromodomain and extraterminal protein inhibitor drug, processes for preparation thereof, and use thereof

GENZYME CORP

Crystalline form of Tolebrutinib